Munich Reinsurance Co Stock Corp in Munich Invests $6.53 Million in Cigna Group $CI

Munich Reinsurance Co Stock Corp in Munich purchased a new position in shares of Cigna Group (NYSE:CIFree Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 22,646 shares of the health services provider’s stock, valued at approximately $6,528,000.

A number of other large investors also recently bought and sold shares of CI. Harbor Capital Advisors Inc. increased its stake in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the period. Collier Financial purchased a new stake in shares of Cigna Group during the third quarter valued at $34,000. Traub Capital Management LLC bought a new position in shares of Cigna Group in the second quarter worth about $48,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of Cigna Group in the second quarter worth about $52,000. Finally, CNB Bank increased its stake in Cigna Group by 479.4% in the 3rd quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after buying an additional 163 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Robert W. Baird lowered their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Cigna Group in a research report on Wednesday. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Mizuho set a $325.00 price objective on Cigna Group in a research note on Friday, January 9th. Finally, Barclays reduced their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $330.42.

View Our Latest Analysis on CI

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by corporate insiders.

Cigna Group Trading Down 3.5%

NYSE:CI opened at $271.50 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market cap of $71.55 billion, a P/E ratio of 12.24, a P/E/G ratio of 0.94 and a beta of 0.27. The firm has a 50-day simple moving average of $280.71 and a 200-day simple moving average of $284.11.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter in the prior year, the company earned $6.64 EPS. The company’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is presently 28.13%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.